QQ客服 官方微博 反馈留言

	Synergistic efficacy of the demethylation agent decitabine in combination with the protease inhibitor bortezomib for treating multiple myeloma through the Wnt/βcatenin pathway.
	Yulong Jin; Li Xu; Xiaodong Wu; Juan Feng; Mimi Shu; Hongtao Gu; Guangxun Gao; Jinyi Zhang; Baoxiao Dong; Xiequn Chen
刊名	Oncology research
	2019
ISSN号	1555-3906
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4744850
专题	湖南大学
作者单位	Department of Hematology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, Shaanxi, China. Department of Cell Biology, Fourth Military Medical University, Xi'an 710032, Shaanxi,China.
推荐引用方式 GB/T 7714	Yulong Jin,Li Xu,Xiaodong Wu,et al. Synergistic efficacy of the demethylation agent decitabine in combination with the protease inhibitor bortezomib for treating multiple myeloma through the Wnt/βcatenin pathway.[J]. Oncology research,2019.
APA	Yulong Jin.,Li Xu.,Xiaodong Wu.,Juan Feng.,Mimi Shu.,...&Xiequn Chen.(2019).Synergistic efficacy of the demethylation agent decitabine in combination with the protease inhibitor bortezomib for treating multiple myeloma through the Wnt/βcatenin pathway..Oncology research.
MLA	Yulong Jin,et al."Synergistic efficacy of the demethylation agent decitabine in combination with the protease inhibitor bortezomib for treating multiple myeloma through the Wnt/βcatenin pathway.".Oncology research (2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。